To include your compound in the COVID-19 Resource Center, submit it here.

Makena hydroxyprogesterone caproate injection regulatory update

FDA granted accelerated approval for an NDA from Hologic for Makena hydroxyprogesterone caproate injection to reduce the risk of preterm

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE